Hill-Rom Holdings Inc (HRC) 50.10 $HRC
Hill-Rom: Welch-Allyn Buyout Drives Q2, Forex Woes Stay
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:20AM CDT
Hill-Rom (HRC) posted a mixed second quarter of fiscal 2016 with the bottom line surpassing the Zacks Consensus Estimate and the top line missing the same.
BSX: 23.02 (-0.30), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06), HRC: 50.10 (-1.12)
Hill-Rom to Participate in the Goldman Sachs 37th Annual Global Healthcare Conference
PR Newswire - Tue May 24, 9:00AM CDT
Hill-Rom Holdings, Inc., (NYSE: HRC) invites you to listen to a management presentation at the Goldman Sachs 37th Annual Global Healthcare Conference on Tuesday, June 7, 2016, at 11:00 a.m. EDT.
HRC: 50.10 (-1.12)
Hill-Rom to Participate in the Goldman Sachs First Annual Leveraged Finance Conference
PR Newswire - Fri May 06, 1:30PM CDT
Hill-Rom Holdings, Inc., (NYSE: HRC) invites you to listen to a management presentation at the Goldman Sachs First Annual Leveraged Finance Conference on Tuesday, May 17, 2016, at 8:10 p.m. EDT.
HRC: 50.10 (-1.12)
Hill-Rom Declares Third Quarter 2016 Dividend
PR Newswire - Fri May 06, 8:00AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that its Board of Directors declared a fiscal year 2016 third quarter dividend of $0.17 per share. This quarterly dividend represents a 6 percent increase over the amount paid a year ago. The dividend is payable on June 24, 2016, to shareholders of record as of the close of business on June 10, 2016.
HRC: 50.10 (-1.12)
Hill-Rom (HRC) Q2 Earnings Beat, Revenue Lag Estimates
Zacks Equity Research - Zacks Investment Research - Wed May 04, 8:05AM CDT
Hill-Rom (HRC) ended second-quarter fiscal 2016 on a mixed note with the bottom line surpassing the Zacks Consensus Estimate and top line missing the mark.
BSX: 23.02 (-0.30), SRDX: 23.19 (-0.11), BAX: 44.49 (-0.26), HRC: 50.10 (-1.12)
Hill-Rom to Participate in the Bank of America Merrill Lynch 2016 Health Care Conference
PR Newswire - Tue May 03, 12:00PM CDT
Hill-Rom Holdings, Inc. (NYSE:HRC) invites you to listen to a management presentation at the Bank of America Merrill Lynch 2016 Health Care Conference on Tuesday, May 10, 2016, at 5:20 p.m. EDT.
HRC: 50.10 (-1.12)
Hill-Rom tops 2Q profit forecasts
Automated Insights - Fri Apr 29, 5:37AM CDT
CHICAGO (AP) _ Hill-Rom Holdings Inc. (HRC) on Friday reported fiscal second-quarter earnings of $22.3 million.
HRC: 50.10 (-1.12)
Hill-Rom Reports Higher Year-Over-Year Revenue And Adjusted Earnings And Updates Full Year Outlook
PR Newswire - Fri Apr 29, 5:00AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) announced financial results for its second quarter ended March 31, 2016, and updated its fiscal year 2016 financial outlook. Adjusted earnings per diluted share of $0.71 represent an increase of 11 percent from $0.64 in the prior year, while reported earnings per diluted share decreased 27 percent from $0.45 to $0.33. Adjustments to reported earnings are detailed in the reconciliation schedules provided.
HRC: 50.10 (-1.12)
Hill-Rom to Participate in the Deutsche Bank 41st Annual Health Care Conference
PR Newswire - Tue Apr 26, 10:30AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) invites you to listen to a management presentation at the Deutsche Bank 41st Annual Health Care Conference on Wednesday, May 4, 2016, at 2:50 p.m. EDT.
DB: 15.74 (-0.97), HRC: 50.10 (-1.12)
Hill-Rom Holdings, Inc. Hosts Fiscal 2016 Second Quarter Earnings Conference Call and Webcast
PR Newswire - Fri Apr 01, 10:30AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) will hold its fiscal 2016 second quarter earnings conference call and webcast on Friday, April 29, 2016, from 8:00 a.m. - 9:00 a.m. EDT.
HRC: 50.10 (-1.12)
Medtronic Unveils NURO System in US for Overactive Bladder
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 12:30PM CDT
We believe this product launch will allow Medtronic (MDT) to overcome the issues it has been facing in its Neuromodulation business division over the past couple of quarters
MDT: 85.70 (-0.08), OFIX: 46.16 (-1.09), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Mead Johnson Launches Enfinitas Product Line in China
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 12:25PM CDT
Mead Johnson Nutrition Company (MJN) recently launched its Enfinitas premium-priced product line in China.
MJN: 83.79 (-0.38), BAX: 44.49 (-0.26), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Quest Diagnostics Grows Through Organic, Inorganic Means
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 3:05PM CDT
On Mar 30, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
BAX: 44.49 (-0.26), DGX: 77.45 (-1.30), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Cepheid Up on International Launch of Next-Gen MRSA Test
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 2:50PM CDT
Cepheid's (CPHD) Xpert MRSA NxG assay is a next-generation version of the market-leading molecular diagnostic test for Methicillin-Resistant Staphyloccus aureus (MRSA).
CPHD: 28.27 (-0.60), OFIX: 46.16 (-1.09), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Stryker (SYK) Scales a 52-Week High: Right Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 11:40AM CDT
Shares of Stryker Corp (SYK) rallied to a new 52-week high of $106.92 on Mar 29, eventually closing a tad bit lower at $106.87.
BAX: 44.49 (-0.26), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13), SYK: 114.56 (-0.77)
Akers' Loss Widens in 2015, Revenues Deteriorate Y/Y
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 9:46AM CDT
Akers Biosciences Inc. (AKER) reported loss of $1.81 per share in full-year 2015, much wider than 66 cents recorded in 2014.
AMZN: 717.91 (-9.74), BAX: 44.49 (-0.26), AKER: 2.00 (-0.08), HRC: 50.10 (-1.12)
Cardiovascular Systems: Market Dynamics, Margins Strong
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 1:45PM CDT
Currently, Cardiovascular Systems (CSII) stands to gain from several favorable trends existing in the PAD as well CAD market spaces
CSII: 18.36 (+0.41), OFIX: 46.16 (-1.09), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Thermo Fisher to Acquire Affymetrix, Origin's Bid Falls Flat
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 1:40PM CDT
On completion, the Thermo Fisher(TMO)-Affymetrix (AFFX) deal is expected to generate attractive financial returns
TMO: 151.80 (-2.35), AFFX: 14.01 (+0.02), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Cepheid: Test Menu Expansion Strong, Currency Woes Stay
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 1:00PM CDT
Although Cepheid's (CPHD) revenues in the fourth quarter steered ahead of the Zacks Consensus Estimate, the massive slip on the bottom-line front, on a year-over-year basis, was disappointing.
LMAT: 15.03 (-0.06), CPHD: 28.27 (-0.60), OFIX: 46.16 (-1.09), HRC: 50.10 (-1.12)
Boston Scientific Unveils Stent for Pancreatitis Complications
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 12:50PM CDT
Boston Scientific's (BSX) MRI-compatible Axios stent is the the world's first stent that facilitates pancreatic fluid collection (PFC).
BSX: 23.02 (-0.30), LMAT: 15.03 (-0.06), OFIX: 46.16 (-1.09), HRC: 50.10 (-1.12)
Hill-Rom: Welch-Allyn Buyout Drives Q2, Forex Woes Stay
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:20AM CDT
Hill-Rom (HRC) posted a mixed second quarter of fiscal 2016 with the bottom line surpassing the Zacks Consensus Estimate and the top line missing the same.
BSX: 23.02 (-0.30), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06), HRC: 50.10 (-1.12)
Hill-Rom to Participate in the Goldman Sachs 37th Annual Global Healthcare Conference
PR Newswire - Tue May 24, 9:00AM CDT
Hill-Rom Holdings, Inc., (NYSE: HRC) invites you to listen to a management presentation at the Goldman Sachs 37th Annual Global Healthcare Conference on Tuesday, June 7, 2016, at 11:00 a.m. EDT.
HRC: 50.10 (-1.12)
Hill-Rom to Participate in the Goldman Sachs First Annual Leveraged Finance Conference
PR Newswire - Fri May 06, 1:30PM CDT
Hill-Rom Holdings, Inc., (NYSE: HRC) invites you to listen to a management presentation at the Goldman Sachs First Annual Leveraged Finance Conference on Tuesday, May 17, 2016, at 8:10 p.m. EDT.
HRC: 50.10 (-1.12)
Hill-Rom Declares Third Quarter 2016 Dividend
PR Newswire - Fri May 06, 8:00AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that its Board of Directors declared a fiscal year 2016 third quarter dividend of $0.17 per share. This quarterly dividend represents a 6 percent increase over the amount paid a year ago. The dividend is payable on June 24, 2016, to shareholders of record as of the close of business on June 10, 2016.
HRC: 50.10 (-1.12)
Hill-Rom (HRC) Q2 Earnings Beat, Revenue Lag Estimates
Zacks Equity Research - Zacks Investment Research - Wed May 04, 8:05AM CDT
Hill-Rom (HRC) ended second-quarter fiscal 2016 on a mixed note with the bottom line surpassing the Zacks Consensus Estimate and top line missing the mark.
BSX: 23.02 (-0.30), SRDX: 23.19 (-0.11), BAX: 44.49 (-0.26), HRC: 50.10 (-1.12)
Hill-Rom to Participate in the Bank of America Merrill Lynch 2016 Health Care Conference
PR Newswire - Tue May 03, 12:00PM CDT
Hill-Rom Holdings, Inc. (NYSE:HRC) invites you to listen to a management presentation at the Bank of America Merrill Lynch 2016 Health Care Conference on Tuesday, May 10, 2016, at 5:20 p.m. EDT.
HRC: 50.10 (-1.12)
Hill-Rom tops 2Q profit forecasts
Automated Insights - Fri Apr 29, 5:37AM CDT
CHICAGO (AP) _ Hill-Rom Holdings Inc. (HRC) on Friday reported fiscal second-quarter earnings of $22.3 million.
HRC: 50.10 (-1.12)
Hill-Rom Reports Higher Year-Over-Year Revenue And Adjusted Earnings And Updates Full Year Outlook
PR Newswire - Fri Apr 29, 5:00AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) announced financial results for its second quarter ended March 31, 2016, and updated its fiscal year 2016 financial outlook. Adjusted earnings per diluted share of $0.71 represent an increase of 11 percent from $0.64 in the prior year, while reported earnings per diluted share decreased 27 percent from $0.45 to $0.33. Adjustments to reported earnings are detailed in the reconciliation schedules provided.
HRC: 50.10 (-1.12)
Hill-Rom to Participate in the Deutsche Bank 41st Annual Health Care Conference
PR Newswire - Tue Apr 26, 10:30AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) invites you to listen to a management presentation at the Deutsche Bank 41st Annual Health Care Conference on Wednesday, May 4, 2016, at 2:50 p.m. EDT.
DB: 15.74 (-0.97), HRC: 50.10 (-1.12)
Hill-Rom Holdings, Inc. Hosts Fiscal 2016 Second Quarter Earnings Conference Call and Webcast
PR Newswire - Fri Apr 01, 10:30AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) will hold its fiscal 2016 second quarter earnings conference call and webcast on Friday, April 29, 2016, from 8:00 a.m. - 9:00 a.m. EDT.
HRC: 50.10 (-1.12)
Medtronic Unveils NURO System in US for Overactive Bladder
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 12:30PM CDT
We believe this product launch will allow Medtronic (MDT) to overcome the issues it has been facing in its Neuromodulation business division over the past couple of quarters
MDT: 85.70 (-0.08), OFIX: 46.16 (-1.09), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Mead Johnson Launches Enfinitas Product Line in China
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 12:25PM CDT
Mead Johnson Nutrition Company (MJN) recently launched its Enfinitas premium-priced product line in China.
MJN: 83.79 (-0.38), BAX: 44.49 (-0.26), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Quest Diagnostics Grows Through Organic, Inorganic Means
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 3:05PM CDT
On Mar 30, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
BAX: 44.49 (-0.26), DGX: 77.45 (-1.30), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Cepheid Up on International Launch of Next-Gen MRSA Test
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 2:50PM CDT
Cepheid's (CPHD) Xpert MRSA NxG assay is a next-generation version of the market-leading molecular diagnostic test for Methicillin-Resistant Staphyloccus aureus (MRSA).
CPHD: 28.27 (-0.60), OFIX: 46.16 (-1.09), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Stryker (SYK) Scales a 52-Week High: Right Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 11:40AM CDT
Shares of Stryker Corp (SYK) rallied to a new 52-week high of $106.92 on Mar 29, eventually closing a tad bit lower at $106.87.
BAX: 44.49 (-0.26), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13), SYK: 114.56 (-0.77)
Akers' Loss Widens in 2015, Revenues Deteriorate Y/Y
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 9:46AM CDT
Akers Biosciences Inc. (AKER) reported loss of $1.81 per share in full-year 2015, much wider than 66 cents recorded in 2014.
AMZN: 717.91 (-9.74), BAX: 44.49 (-0.26), AKER: 2.00 (-0.08), HRC: 50.10 (-1.12)
Cardiovascular Systems: Market Dynamics, Margins Strong
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 1:45PM CDT
Currently, Cardiovascular Systems (CSII) stands to gain from several favorable trends existing in the PAD as well CAD market spaces
CSII: 18.36 (+0.41), OFIX: 46.16 (-1.09), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Thermo Fisher to Acquire Affymetrix, Origin's Bid Falls Flat
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 1:40PM CDT
On completion, the Thermo Fisher(TMO)-Affymetrix (AFFX) deal is expected to generate attractive financial returns
TMO: 151.80 (-2.35), AFFX: 14.01 (+0.02), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Cepheid: Test Menu Expansion Strong, Currency Woes Stay
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 1:00PM CDT
Although Cepheid's (CPHD) revenues in the fourth quarter steered ahead of the Zacks Consensus Estimate, the massive slip on the bottom-line front, on a year-over-year basis, was disappointing.
LMAT: 15.03 (-0.06), CPHD: 28.27 (-0.60), OFIX: 46.16 (-1.09), HRC: 50.10 (-1.12)
Boston Scientific Unveils Stent for Pancreatitis Complications
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 12:50PM CDT
Boston Scientific's (BSX) MRI-compatible Axios stent is the the world's first stent that facilitates pancreatic fluid collection (PFC).
BSX: 23.02 (-0.30), LMAT: 15.03 (-0.06), OFIX: 46.16 (-1.09), HRC: 50.10 (-1.12)
